AKAhmet Keles

Ahmet Keles

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ahmet Keles has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Outcomes of BCG Therapy in Patients with High and Very High-Risk Non-Muscle-Invasive Bladder Cancer: Reassessing EAU Risk Stratification

    by Özgür Arıkan, Ayberk İpLikçi, Hüseyin Özgür Kazan, Ahmet Keleş, Ferhat Keser, İlKin-Hamid Zada, Mehmet Çağlar Çakıcı, Meftun Çulpan, Asıf Yıldırım

    Objective: To evaluate the oncologic outcomes of high-risk (HR) and very high-risk (VHR) non-muscle-invasive bladder cancer (NMIBC) patients treated with Bacillus Calmette-Guérin (BCG) immunotherapy and assess the new European Association of Urology (EAU) risk stratification. Material and Methods: This retrospective cohort study analyzed data from 211 HR and VHR NMIBC patients treated with BCG therapy between January 2015 and January 2024. Risk stratification was performed using the EAU NMIBC risk calculator. Recurrence, progression, recurrence-free survival (RFS), and progression-free survival (PFS) were assessed. Results: The cohort comprised 144 (68.2%) HR and 67 (31.8%) VHR patients. The VHR group had significantly more adverse pathological features (larger and multiple tumors, higher pT stage, CIS, variant histology, lymphovascular invasion, tumor necrosis). While there was no significant difference in overall recurrence (33.3% vs. 37.3%, p=0.572) or progression rates (10.4% vs. 9%, p=0.741) between HR and VHR groups, the 5-year RFS was significantly lower in the VHR (56% vs. 75%, p=0.003). The 5-year PFS was similar between the groups (86% vs 91%, p=0.311). Conclusion: In spite of the fact that the VHR group presented with more aggressive tumor characteristics, BCG therapy resulted in similar overall progression rates compared to the HR group. These findings suggest that the EAU risk stratification may overestimate the risk of progression in BCG-treated patients, particularly those classified as VHR, and that BCG remains a valuable treatment option even in this population.

  • Does Timing of Retrograde Intrarenal Surgery Following Extracorporeal Shock Wave Lithotripsy Failure Influence the Outcomes?

    by Özgür Arıkan, Ferhat Keser, Ayberk İplikçi, Hüseyin Özgür Kazan, Ahmet Keleş, Ilkın Hamıdzada, Muhammet Talha Nuroğlu, Adnan Başaran, Meftun Çulpan, Asıf Yıldırım

    Objective: The objective of this study is to determine the impact of the timing of retrograde intrarenal surgery (RIRS) following extracorporeal shock wave lithotripsy (SWL) on renal stone treatment outcomes. Material and Methods: This retrospective study included 138 patients who underwent RIRS for renal stones after at least two failed SWL sessions between 2020 and 2024. Patients were divided into three groups based on the time interval between SWL and RIRS: 7-14 days (group 1), 15-22 days (group 2), and 23-30 days (group 3). Demographic data, stone characteristics, operative time, stone-free rate, and complication rates were compared. Results: Stone-free rates were similar across the three groups (group 1: 85.4%, group 2: 84.8%, group 3: 86.3%, p=0.978). There were no statistically significant differences between the groups in terms of median operative time (p=0.249), median length of hospital stays (p=0.865), perioperative complications (p=0.884), or postoperative complications (p=0.962). Conclusions: The timing of RIRS after failed SWL does not appear to impact treatment outcomes for renal stones significantly, and these findings suggest flexibility in scheduling RIRS after SWL failure.

  • Open Access

    Exploring the influence of health and digital health literacy on quality of life and follow-up compliance in patients with primary non-muscle invasive bladder cancer: a prospective, single-center study

    by Ahmet Keles, Umit Furkan Somun, Muhammed Kose, Ozgur Arikan, Meftun Culpan, Asif Yildirim

    Objective: Given the increasing significance of digital health literacy (DHL) and health literacy (HL) in promoting informed decision-making and healthy behaviors, this study aimed to assess the influence of self-reported HL and DHL on treatment adherence and quality of life among patients who underwent transurethral resection of bladder tumors (TUR-BT) for primary non-muscle invasive bladder cancer (NMIBC). Materials & methods: This single-center observational study involved patients who underwent TUR-BT for NIMBC at a tertiary hospital from May 2022 to February 2024. Before the procedure, the patients’ DHL and HL were evaluated using the European Health Literacy Survey Questionnaire short version and the eHealth Literacy Scale. Six months after surgery, we surveyed patients’ QoL using the EORTC QLQ-C30. In line with recommendations from the European Association of Urology guidelines, adherence to the treatment plan was assessed along with a follow-up cystoscopy examination for each patient. Results: Multivariate analysis revealed that poorer DHL and HL were significantly associated with older age ( p < 0.001), lower educational attainment ( p < 0.001), and lack of internet access ( p < 0.001). Conversely, higher DHL and HL levels were positively correlated with increased treatment adherence, as measured by cystoscopy completion ( p < 0.001). Additionally, logistic regression analysis demonstrated significant associations between improved DHL and HL scores and better global health status (DHL, p = 0.022; HL, p = 0.008), higher emotional status ( p < 0.001 for both), and social functioning ( p < 0.001 for both). Notably, there were no significant differences in the symptom scale scores between the DHL and HL groups. Conclusion: To the best of our knowledge, this is the first study to explore the specific effect of HL/DHL on QoL and adherence in this patient population. Our research suggests that there may be a link between self-reported levels of DHL/HL and treatment adherence as well as QoL among patients with NIMBC.


  • Radikal Prostatektomi Sonrası Erken Dönem Komplikasyonları Etkileyen Faktörlerin Değerlendirilmesi

    by Ozgur Arıkan, Ferhat Keser, Ayberk İplikçi, Ahmet Keleş, Özgür Efiloğlu, Asıf Yıldırım

    Amaç: Radikal prostatektomi (RP) sonrası komplikasyonları ve erken dönemde hastaneye tekrar başvuruları azaltmak öngörücü faktörlerin belirlenmesiyle sağlanabilir. Bu çalışmanın amacı RP uygulanan hastalarda, hastanede kalış süresinde uzama ve postoperatif erken dönemde hastaneye tekrar başvuruları öngörmede etkili parametreleri araştırmaktır. İkinci amaç ise bu hastalardan yaşlı grupta (65 yaş ve üzeri) postoperatif komplikasyon gelişiminde etkili parametreleri belirlemektir. Materyal ve Metod: Retrospektif olarak yapılan çalışmada Şubat 2022 ile Şubat 2023 arasında prostat kanseri tanısı ile kliniğimizde açık retropubik RP uygulanan hastaların verileri değerlendirildi. Komorbidite durumları Charlson Komorbidite İndeksi (CCİ) ile; malnütrisyon durumları ise mini nütrisyonel değerlendirme (MNA) testi ile değerlendirildi. Bulgular: Toplam 27 hastada (%27) postoperatif erken dönemde komplikasyon gelişti. MNA testine göre hiçbir hasta malnütrisyonlu değildi. Hastaların büyük çoğunluğunun (%91) beslenmesi normaldi. Postoperatif erken dönemde komplikasyon gelişen hastalar ile gelişmeyen hastalar karşılaştırıldığında (grup 1 vs. grup 2), sigara kullanımı, kilo, VKİ, hemoglobin, eGFR, ALT, AST ve albumin değerleri arasında fark izlenmedi. İki grup arasında MNA testi karşılaştırıldığında, komplikasyon gelişenlerde ortalama malnütrisyon skoru daha düşüktü ve bu istatistiksel olarak anlamlı bulundu (grup 1:25,5 vs. grup 2:26,4, p=0,019). Komplikasyon gelişenler; yatış süresi uzayanlar (grup P) ve taburculuk sonrası erken dönemde tekrar hastaneye başvuranlar (grup R) olarak iki gruba ayrıldığında, 17 (%17) hastanın yatış süresinin uzadığı, 10 (%10) hastanın postoperatif erken dönemde tekrar başvuruda bulunduğu görüldü. İki grup karşılaştırılarak alt grup analizi yapıldığında ortalama MNA skoru (grup P:26,2±2,0 vs. grup R:24,3±1,0, p=0,005) R grubunda istatistiksel anlamlı olarak daha düşüktü. Uzamış yatış süresi için risk faktörlerine bakıldığında, çok değişkenli regresyon analizinde CCİ (p=0,006) bağımsız risk faktörü olarak belirlendi. Hastaneye tekrar başvuru için risk faktörlerine bakıldığında, çok değişkenli regresyon analizinde malnütrisyon riski (p=0,035) bağımsız risk faktörü olarak belirlendi. Sonuç: Lokal evre prostat kanseri tanısıyla RP uygulanan hastalarda; MNA skoru, yaş ve boy ölçüsü, postoperatif erken dönemde komplikasyon gelişimi için birer prediktör olabilir. Yaşlı hastalarda ise; malnütrisyon riski ve komorbidite sayısı, postoperatif komplikasyonları öngörmek için değerli görülmüştür.

  • Role of Metastasectomy in Prostate Cancer Patients Following Curative Treatment

    by Burak Tufekci, Ahmet Keles

    In this section, we explore the outcomes of metastasectomy in prostate cancer patients. Systemic treatments for low-volume metastatic prostate cancer often lead to various side effects. However, in carefully selected cases, direct treatment methods such as metastasectomy or stereotactic body radiotherapy (SBRT) are used to control the disease in its early stages, providing an alternative to systemic treatments. Metastasectomy is particularly preferred for isolated metachronous metastases identified by PSMA PET scans.

  • Conventional and Investigational Imaging Techniques

    by Burak Tufekci, Ahmet Keles

    This chapter highlights the evolution and current advancements in bladder cancer imaging, underscoring the need for ongoing research to optimize imaging modalities and integrate novel technologies in clinical practice. Bladder cancer imaging plays a crucial role in the diagnosis, staging, and treatment planning of the disease, distinguishing between non-muscle-invasive and muscle-invasive tumors. Emerging techniques and artificial intelligence are increasingly significant, enhancing diagnostic accuracy and enabling personalized treatment strategies.

  • Urine Biomarkers for Bladder Cancer

    by Ahmet Keles

    Urine biomarkers for bladder cancer, explored in this chapter, assess their potential in enhancing diagnostic accuracy, monitoring recurrence, and improving surveillance protocols. The chapter discusses various biomarkers like EpiCheckTM, Xpert® Bladder Cancer Monitor, ADX BladderTM, and Cxbladder, evaluating their sensitivity and specificity for detecting high-grade tumors and their integration into clinical practice as adjuncts or alternatives to traditional methods like cystoscopy.

  • Open Access

    Exploring the impact of digital health literacy on quality of life in patients undergoing retrograde intrarenal surgery for kidney stone treatment: a prospective, single-center study

    by Ahmet Keles, Ozgur Arikan, İlKin Hamid-Zada, Umit Furkan Somun, Kursad Nuri Baydili, Asif Yildirim

    Retrograde intrarenal surgery (RIRS) is the recommended treatment for renal stones up to two cm in size. As digital health literacy (e-HL) has become increasingly important in promoting informed health decisions and healthy behaviors, it is necessary to investigate its impact on RIRS treatment outcomes. We aimed to explore the influence of patients’ e-HL level on their postoperative quality of life (QoL). We conducted an observational prospective study of 111 patients who underwent RIRS for renal pelvis stones. Before RIRS, we evaluated patients’ e-HL using the electronic health literacy scale (eHEALS). QoL was evaluated using the five-level EuroQol five-dimensional questionnaire (EQ-5D-5L) one month after RIRS. SFR was determined by a negative CT scan or asymptomatic patients with stone fragments < 3 mm. Adult individuals aged 18 years or older with typical calyceal anatomy met the eligibility criteria for enrollment. Exclusion criteria for the study included patients with ureteric stones, anomalous kidneys, or bilateral renal stones. The relationship between patients’ QoL and stone-free rate was explored using Spearman’s rank correlation coefficient. The mean stone burden was 14 ± 3 mm (6–19 mm). The overall SFR was 83.3% after one month. The median EQ-5D-5L utility index and VAS score were 0.826 (0.41–1) and 70 (20–100) respectively, for the overall population. We found that poorer e-HL was associated with being older (p = 0.035), having less education (p = 0.005), and not having access to the internet (p < 0.001). A significant difference was observed between patients with sufficient e-HL and patients with limited e-HL in the self-care (p = 0.02) and anxiety/depression (p = 0.021) dimensions. To date, no study has examined the impact of patients’ e-HL levels on postoperative QoL in patients undergoing RIRS. This study also revealed that e-HL levels in patients undergoing RIRS were related to postoperative QoL, especially self-care and anxiety/depression dimensions, whereas there was no relationship between them and SFR.


  • Open Access

    Evolving horizons in renal angiomyolipoma: two decades of management strategies and clinical perspectives in a single institutional study

    by Ahmet Keles, Ayberk Iplikci, Ozgur Arikan, Meftun Culpan, Kursad Nuri Baydili, Ferhat Keser, Asif Yildirim

    To assess various management options for renal angiomyolipoma (AML) to guide clinical practice. A single center retrospectively reviewed an AML series from 2002 to 2022. The image reports and chart reviews of patients who received two abdominal scans at least 6 months between the first and last scans were assessed. A total of 203 patients with 209 tumors were identified and followed up for a median of 42.6 months. Active surveillance (AS) was the most frequently selected option (70.9% of cases). Interventions were required for 59 AMLs, of which 20 were treated with embolization, 29 with partial nephrectomy, 9 with radical nephrectomy, and 1 with radiofrequency (RF) ablation. The median size of the lesions at intervention was 5 cm. The average growth rate of the lesions was 0.12 cm/year, and there was a significant difference in the average growth rate of lesions ≤4 cm and those >4 cm (0.11 vs. 0.24 cm/year; p = 0.0046). This series on AMLs confirms that lesions >4 cm do not require early intervention based on size alone. Appropriately selected cases of renal AML can be managed by AS.KEYWORDS: Angiomyolipoma; active surveillance; embolization; nephrectomy; nephron-sparing surgery.